We are live on ! Find out more
CLPT icon

ClearPoint Neuro
CLPT

28 hedge funds and large institutions have $4.06M invested in ClearPoint Neuro in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0% more funds holding

Funds holding: 28 → 28 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.89% less ownership

Funds ownership: 8.25% → 7.37% (-0.89%)

13% less capital invested

Capital invested by funds: $4.65M → $4.06M (-$583K)

Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$154K
2
Renaissance Technologies
Renaissance Technologies
New York
+$82.9K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.86K
4
Bank of America
Bank of America
North Carolina
+$692
5
TRCT
Tower Research Capital (TRC)
New York
+$398

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$489K
2
MWM
Merriman Wealth Management
Washington
-$182K
3
Millennium Management
Millennium Management
New York
-$38.3K
4
WVP
Worth Venture Partners
New Jersey
-$16.9K
5
Morgan Stanley
Morgan Stanley
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.62M – – –
PCM
2
Parsons Capital Management
Rhode Island
$539K – – –
WVP
3
Worth Venture Partners
New Jersey
$272K -$16.9K -4,550 -6%
Renaissance Technologies
4
Renaissance Technologies
New York
$180K +$82.9K +22,300 +79%
BlackRock
5
BlackRock
New York
$177K +$154K +41,529 +498%
MWM
6
Merriman Wealth Management
Washington
$170K -$182K -49,010 -51%
MC
7
Mayo Clinic
Minnesota
$168K – – –
Millennium Management
8
Millennium Management
New York
$155K -$38.3K -10,294 -19%
KMC
9
Kirr Marbach & Co
Indiana
$150K – – –
Brown Advisory
10
Brown Advisory
Maryland
$100K – – –
PHP
11
Parkman Healthcare Partners
Connecticut
$89K – – –
SAM
12
Silvercrest Asset Management
New York
$84K – – –
WJWM
13
Williams Jones Wealth Management
New York
$77K – – –
IC
14
IEQ Capital
California
$71K – – –
WMC
15
Westwood Management Corporation
Illinois
$62K – – –
RFC
16
Regions Financial Corp
Alabama
$41K – – –
Northern Trust
17
Northern Trust
Illinois
$39K – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$38K – – –
Bank of America
19
Bank of America
North Carolina
$12K +$692 +186 +6%
MFT
20
Moisand Fitzgerald Tamayo
Florida
$8K – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$5K +$30 +8 +0.5%
Osaic Holdings
22
Osaic Holdings
Arizona
$4K – – –
OIA
23
Optimum Investment Advisors
Illinois
$2K – – –
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$2K +$1.86K +500 New
EI
25
EAM Investors
California
– -$489K -136,525 Closed
1
2

CLPT Hedge Fund Activity: Q2 2020 in Review

28 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2020, worth a combined $4.06M — down 13% from $4.65M a quarter earlier.

Fund positioning in CLPT was balanced in Q2 2020: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $154K. The largest seller was EAM Investors, exiting entirely with an estimated $489K sold.

  • 28 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $4.06M of ClearPoint Neuro stock for Q2 2020, down 13% quarter-over-quarter.
  • 2 funds opened new ClearPoint Neuro positions in Q2 2020 and 2 closed out, a net change of 0 holders.
  • The largest ClearPoint Neuro buyer in Q2 2020 was BlackRock, an estimated $154K added.
  • The largest ClearPoint Neuro seller in Q2 2020 was EAM Investors, an estimated $489K sold.

Based on aggregated 13F filings for Q2 2020.